MedPath

STIMVIA s.r.o.

🇨🇿Czech Republic
Ownership
-
Employees
-
Market Cap
-
Website

24-months Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

Not Applicable
Recruiting
Conditions
Parkinson Disease
Essential Tremor
Interventions
Device: Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)
First Posted Date
2024-08-26
Last Posted Date
2024-08-26
Lead Sponsor
Stimvia s.r.o.
Target Recruit Count
20
Registration Number
NCT06570421
Locations
🇨🇿

Cerebrovaskulární poradna s.r.o., Ostrava, Czechia

Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor

Not Applicable
Completed
Conditions
Essential Tremor
Parkinson's Disease
Interventions
Device: Peroneal electrical transcutaneous neuromodulation (peroneal eTNM®)
First Posted Date
2023-09-13
Last Posted Date
2024-08-21
Lead Sponsor
Stimvia s.r.o.
Target Recruit Count
23
Registration Number
NCT06036368
Locations
🇨🇿

Cerebrovaskulární poradna s.r.o., Ostrava, Czechia

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

Completed
Conditions
Overactive Bladder (OAB)
Failed Any OAB Pharmacotherapy
Interventions
Device: eTNM delivered by URIS I nerve stimulation device
First Posted Date
2022-01-27
Last Posted Date
2022-02-17
Lead Sponsor
Stimvia s.r.o.
Target Recruit Count
40
Registration Number
NCT05211193
Locations
🇨🇿

MUDr. Michal Rejchrt, Příbram, Czech, Czechia

© Copyright 2025. All Rights Reserved by MedPath